SUBSCRIBE
SUBSCRIBE
News   Drug Development

miRagen To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference July 13, 2016

July 6, 2016 | 
1 min read
BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing innovative microRNA-based therapeutics, today announced its participation in the Cantor Fitzgerald 2nd Annual Healthcare Conference.

Conference Details:

The Cantor Fitzgerald 2nd Annual Healthcare Conference

Clinical research Phase I Events
MORE ON THIS TOPIC
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
May 1, 2025
 · 
3 min read
 · 
Heather McKenzie
Conceptual business illustration of upcoming business problem metaphor with falling domino and businessman silhouette. Minimalistic vector eps 10 illustration
Multiple sclerosis
Immunic Talks Up Disability Gains as Phase II MS Therapy Fails on Primary Endpoint
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Chicago, Illinois, USA on Lake Michigan at dawn.
Cancer
AACR 2025 Tracker: Merck, GSK, Roche and More Present Key Data
April 30, 2025
 · 
8 min read
 · 
BioSpace Editorial Staff
An obstacle to achieving a goal. Concerns and issues. Break through the refusal barrier. Face problems and challenges.
Prostate cancer
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
April 30, 2025
 · 
2 min read
 · 
Tristan Manalac